Dementia Research Group Publications
-
Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures
Sci Rep, 13 (1), 14957
DOI 10.1038/s41598-023-42354-0, PubMed 37696909 -
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
Front Aging Neurosci, 15, 1163184
DOI 10.3389/fnagi.2023.1163184, PubMed 37304077 -
Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease
Alzheimers Dement (in press)
DOI 10.1002/alz.13162, PubMed 37264981 -
Sex-specific associations of matrix metalloproteinases in Alzheimer's disease
Biol Sex Differ, 14 (1), 35
DOI 10.1186/s13293-023-00514-x, PubMed 37221606 -
Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study
Stroke, 54 (5), 1303-1311
DOI 10.1161/STROKEAHA.122.041965, PubMed 37026459 -
Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
Front Aging Neurosci, 15, 1101306
DOI 10.3389/fnagi.2023.1101306, PubMed 36820757 -
Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog) - a national research and quality registry with a biomaterial collection
BMJ Open, 12 (9), e058810
DOI 10.1136/bmjopen-2021-058810, PubMed 36448543 -
Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients
J Clin Invest, 133 (2)
DOI 10.1172/JCI163472, PubMed 36409557 -
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Acta Neuropathol, 144 (5), 821-842
DOI 10.1007/s00401-022-02454-z, PubMed 36066633 -
Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia
Dement Geriatr Cogn Dis Extra, 12 (2), 107-114
DOI 10.1159/000521114, PubMed 35950148 -
Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study
J Alzheimers Dis, 89 (3), 825-834
DOI 10.3233/JAD-220407, PubMed 35938253 -
Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease
Transl Psychiatry, 12 (1), 151
DOI 10.1038/s41398-022-01901-5, PubMed 35397615 -
Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications
Dement Geriatr Cogn Disord, 51 (1), 80-89
DOI 10.1159/000522382, PubMed 35344967 -
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
J Alzheimers Dis, 86 (3), 1459-1470
DOI 10.3233/JAD-215504, PubMed 35213378 -
Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum
J Alzheimers Dis, 86 (3), 1301-1314
DOI 10.3233/JAD-215536, PubMed 35180126 -
One-Year Change in Locus of Control among People with Dementia
Dement Geriatr Cogn Dis Extra, 11 (3), 298-305
DOI 10.1159/000520248, PubMed 35082825 -
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096 -
Neopterin and kynurenic acid as predictors of stroke recurrence and mortality: a multicentre prospective cohort study on biomarkers of inflammation measured three months after ischemic stroke
BMC Neurol, 21 (1), 476
DOI 10.1186/s12883-021-02498-w, PubMed 34879833 -
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
J Alzheimers Dis, 85 (1), 197-205
DOI 10.3233/JAD-215046, PubMed 34776444 -
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study
Front Neurol, 12, 678794
DOI 10.3389/fneur.2021.678794, PubMed 34421786 -
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia
Int Psychogeriatr, 33 (11), 1217-1228
DOI 10.1017/S1041610221000934, PubMed 34399870 -
Investigating novel biomarkers of immune activation and modulation in the context of sedentary behaviour: a multicentre prospective ischemic stroke cohort study
BMC Neurol, 21 (1), 318
DOI 10.1186/s12883-021-02343-0, PubMed 34399717 -
Locus of Control and Its Associations with Depressive Symptoms amongst People with Dementia
Dement Geriatr Cogn Disord, 50 (3), 258-265
DOI 10.1159/000517936, PubMed 34384076 -
Control Beliefs among People with Dementia: A Systematic Review
Dement Geriatr Cogn Disord, 50 (3), 205-223
DOI 10.1159/000516789, PubMed 34153969 -
Pre-stroke cognitive impairment is associated with vascular imaging pathology: a prospective observational study
BMC Geriatr, 21 (1), 362
DOI 10.1186/s12877-021-02327-2, PubMed 34126944 -
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl Neurodegener, 10 (1), 18
DOI 10.1186/s40035-021-00244-3, PubMed 34099032 -
[Alzheimer’s disease – diagnosis and treatment]
Tidsskr Nor Laegeforen, 141 (7)
DOI 10.4045/tidsskr.20.0919, PubMed 33950641 -
Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium
J Alzheimers Dis, 81 (2), 667-677
DOI 10.3233/JAD-201341, PubMed 33814433 -
Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects
Front Aging Neurosci, 13, 624253
DOI 10.3389/fnagi.2021.624253, PubMed 33658917 -
Associations between post-stroke motor and cognitive function: a cross-sectional study
BMC Geriatr, 21 (1), 103
DOI 10.1186/s12877-021-02055-7, PubMed 33546620 -
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front Aging Neurosci, 12, 608628
DOI 10.3389/fnagi.2020.608628, PubMed 33488383 -
Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort
Int J Geriatr Psychiatry, 36 (6), 960-969
DOI 10.1002/gps.5500, PubMed 33462872 -
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
Alzheimers Dement (Amst), 12 (1), e12128
DOI 10.1002/dad2.12128, PubMed 33313376 -
Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
PLoS One, 15 (12), e0243513
DOI 10.1371/journal.pone.0243513, PubMed 33275638 -
Is long-bout sedentary behaviour associated with long-term glucose levels 3 months after acute ischaemic stroke? A prospective observational cohort study
BMJ Open, 10 (11), e037475
DOI 10.1136/bmjopen-2020-037475, PubMed 33243789 -
Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
Int Psychogeriatr, 33 (8), 779-789
DOI 10.1017/S1041610220003270, PubMed 33213607 -
Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification
Sci Rep, 10 (1), 15886
DOI 10.1038/s41598-020-72878-8, PubMed 32985583 -
Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases
Int Rev Neurobiol, 155, 169-202
DOI 10.1016/bs.irn.2020.02.008, PubMed 32854854 -
Post-stroke Cognitive Impairment-Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study
Front Neurol, 11, 699
DOI 10.3389/fneur.2020.00699, PubMed 32765406 -
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke
J Intern Med, 289 (3), 355-368
DOI 10.1111/joim.13161, PubMed 32743852 -
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818 -
The Power of EEG to Predict Conversion from Mild Cognitive Impairment and Subjective Cognitive Decline to Dementia
Dement Geriatr Cogn Disord, 49 (1), 38-47
DOI 10.1159/000508392, PubMed 32610316 -
Young- and Late-Onset Dementia: A Comparative Study of Quality of Life, Burden, and Depressive Symptoms in Caregivers
J Geriatr Psychiatry Neurol, 34 (5), 434-444
DOI 10.1177/0891988720933355, PubMed 32552216 -
COVID-19 pandemic: a multinational report providing professional experiences in the management of mental health of elderly
Int Psychogeriatr, 32 (10), 1153-1156
DOI 10.1017/S1041610220001027, PubMed 32468977 -
Impact of different methods defining post-stroke neurocognitive disorder: The Nor-COAST study
Alzheimers Dement (N Y), 6 (1), e12000
DOI 10.1002/trc2.12000, PubMed 32211505 -
Brazilian version of the European Cross-Cultural Neuropsychological Test Battery (CNTB-BR): diagnostic accuracy across schooling levels
Braz J Psychiatry, 42 (3), 286-294
DOI 10.1590/1516-4446-2019-0539, PubMed 32130401 -
Does hyperglycemia downregulate glucose transporters in the brain?
Med Hypotheses, 139, 109614
DOI 10.1016/j.mehy.2020.109614, PubMed 32087490 -
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
J Alzheimers Dis, 73 (4), 1363-1372
DOI 10.3233/JAD-190941, PubMed 31929159 -
Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register
J Nutr Health Aging, 23 (8), 725-731
DOI 10.1007/s12603-019-1220-z, PubMed 31560030 -
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
BMC Neurol, 19 (1), 223
DOI 10.1186/s12883-019-1447-7, PubMed 31493787 -
The course of depressive symptoms with decline in cognitive function - a longitudinal study of older adults receiving in-home care at baseline
BMC Geriatr, 19 (1), 231
DOI 10.1186/s12877-019-1226-8, PubMed 31443638 -
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334 -
The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
Alzheimer Dis Assoc Disord, 34 (1), 47-53
DOI 10.1097/WAD.0000000000000342, PubMed 31414991 -
Applicability of the locus of control of behaviour scale for people with dementia
Aging Ment Health, 24 (12), 2111-2116
DOI 10.1080/13607863.2019.1652244, PubMed 31402698 -
The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway
Dement Geriatr Cogn Disord, 47 (4-6), 355-365
DOI 10.1159/000501269, PubMed 31319412 -
Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial
Front Psychol, 10, 807
DOI 10.3389/fpsyg.2019.00807, PubMed 31031677 -
Differences in Awareness of Disease Between Young-onset and Late-onset Dementia
Alzheimer Dis Assoc Disord, 33 (2), 129-135
DOI 10.1097/WAD.0000000000000299, PubMed 30870144 -
Corrigendum: Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
Front Aging Neurosci, 11, 37
DOI 10.3389/fnagi.2019.00037, PubMed 30863303 -
Resilience in Carers of People With Young-Onset Alzheimer Disease
J Geriatr Psychiatry Neurol, 32 (2), 59-67
DOI 10.1177/0891988718824039, PubMed 30651027 -
Cortisol levels among older people with and without depression and dementia
Int Psychogeriatr, 31 (4), 597-601
DOI 10.1017/S1041610218001199, PubMed 30556798 -
Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
Front Aging Neurosci, 10, 384
DOI 10.3389/fnagi.2018.00384, PubMed 30519185 -
The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study
BMC Neurol, 18 (1), 193
DOI 10.1186/s12883-018-1198-x, PubMed 30477436 -
Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
PLoS One, 13 (9), e0204436
DOI 10.1371/journal.pone.0204436, PubMed 30240425 -
The Effect of Changing the Amyloid β42 Cut-off of Cerebrospinal Fluid Biomarkers on Alzheimer Disease Diagnosis in a Memory Clinic Population in Norway
Alzheimer Dis Assoc Disord, 33 (1), 72-74
DOI 10.1097/WAD.0000000000000268, PubMed 30106756 -
Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics
BMC Geriatr, 18 (1), 120
DOI 10.1186/s12877-018-0813-4, PubMed 29788900 -
Caregivers' Perspectives of Quality of Life of People With Young- and Late-Onset Alzheimer Disease
J Geriatr Psychiatry Neurol, 31 (2), 76-83
DOI 10.1177/0891988718759601, PubMed 29658428 -
Diagnosing dementia in lower educated older persons: validation of a Brazilian Portuguese version of the Rowland Universal Dementia Assessment Scale (RUDAS)
Braz J Psychiatry, 40 (3), 264-269
DOI 10.1590/1516-4446-2017-2284, PubMed 29451587 -
Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics
J Alzheimers Dis, 61 (3), 1221-1232
DOI 10.3233/JAD-170436, PubMed 29254085 -
Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease
Acta Radiol, 59 (8), 997-1001
DOI 10.1177/0284185117743778, PubMed 29172642 -
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis
PLoS One, 12 (10), e0186595
DOI 10.1371/journal.pone.0186595, PubMed 29036183 -
Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
BMC Geriatr, 17 (1), 210
DOI 10.1186/s12877-017-0611-4, PubMed 28893185 -
Trajectories of depressive symptoms and their relationship to the progression of dementia
J Affect Disord, 222, 146-152
DOI 10.1016/j.jad.2017.07.008, PubMed 28704802 -
Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples
Neuroimage, 158, 282-295
DOI 10.1016/j.neuroimage.2017.06.070, PubMed 28666881 -
Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease
Dement Geriatr Cogn Disord, 44 (1-2), 12-24
DOI 10.1159/000477342, PubMed 28614836 -
[Not Available]
Tidsskr Nor Laegeforen, 137 (10), 685
DOI 10.4045/tidsskr.17.0388, PubMed 28551955 -
Young-onset Alzheimer dementia: a comparison of Brazilian and Norwegian carers' experiences and needs for assistance
Int J Geriatr Psychiatry, 33 (6), 824-831
DOI 10.1002/gps.4717, PubMed 28370411 -
Dissociable diffusion MRI patterns of white matter microstructure and connectivity in Alzheimer's disease spectrum
Sci Rep, 7, 45131
DOI 10.1038/srep45131, PubMed 28338052 -
Virtual Reality-Based Physical Exercise With Exergames (PhysEx) Improves Mental and Physical Health of Institutionalized Older Adults
J Am Med Dir Assoc, 18 (5), 454.e1-454.e9
DOI 10.1016/j.jamda.2017.01.001, PubMed 28238675 -
Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer's disease continuum
Sci Rep, 7, 40268
DOI 10.1038/srep40268, PubMed 28074926 -
The association between attending specialized day care centers and the quality of life of people with dementia
Int Psychogeriatr, 29 (4), 627-636
DOI 10.1017/S1041610216002015, PubMed 27852334 -
Acute effects of exergames on cognitive function of institutionalized older persons: a single-blinded, randomized and controlled pilot study
Aging Clin Exp Res, 29 (3), 387-394
DOI 10.1007/s40520-016-0595-5, PubMed 27256080 -
Quality of life in young onset dementia: an updated systematic review
Trends Psychiatry Psychother, 38 (1), 6-13
DOI 10.1590/2237-6089-2015-0049, PubMed 27074338 -
Performance of Cerebrospinal Fluid Biomarkers of Alzheimer Disease in a Memory Clinic in Norway
Alzheimer Dis Assoc Disord, 30 (1), 8-14
DOI 10.1097/WAD.0000000000000126, PubMed 26629677 -
Confirmatory factor analysis of the Cornell scale for depression in dementia among patient with dementia of various degrees
J Affect Disord, 188, 173-8
DOI 10.1016/j.jad.2015.08.062, PubMed 26363614 -
The course of depressive symptoms as measured by the Cornell scale for depression in dementia over 74 months in 1158 nursing home residents
J Affect Disord, 175, 209-16
DOI 10.1016/j.jad.2014.12.053, PubMed 25638794 -
Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in AD
Arq Neuropsiquiatr, 72 (9), 671-9
DOI 10.1590/0004-282x20140108, PubMed 25252230 -
Nobody asked me how I felt: experiences of adult children of persons with young-onset dementia
Int Psychogeriatr, 26 (12), 1935-44
DOI 10.1017/S1041610213002639, PubMed 24423756 -
Prevalence of depression among memory clinic patients as measured by the Cornell Scale of Depression in Dementia
Aging Ment Health, 18 (5), 579-87
DOI 10.1080/13607863.2013.827630, PubMed 23998196 -
A comparison of the cornell scale for depression in dementia and the Montgomery-Aasberg depression rating scale in a memory clinic population
Dement Geriatr Cogn Disord, 35 (5-6), 256-65
DOI 10.1159/000348345, PubMed 23594823 -
A cross-cultural comparison of the phenotype of depression as measured by the Cornell Scale and the MADRS in two elderly outpatient populations
J Affect Disord, 144 (1-2), 34-41
DOI 10.1016/j.jad.2012.06.003, PubMed 22858259 -
Factors associated with a depressive disorder in Alzheimer's disease are different from those found for other dementia disorders
Dement Geriatr Cogn Dis Extra, 2 (1), 19-28
DOI 10.1159/000335775, PubMed 22479262 -
The validity of the Montgomery-Aasberg depression rating scale as a screening tool for depression in later life
J Affect Disord, 141 (2-3), 227-32
DOI 10.1016/j.jad.2012.02.042, PubMed 22464007 -
A comparison of the validity of the Cornell Scale and the MADRS in detecting depression among memory clinic patients
Dement Geriatr Cogn Disord, 32 (4), 287-94
DOI 10.1159/000334983, PubMed 22262043 -
Validation of Montgomery-Åsberg Rating Scale and Cornell Scale for Depression in Dementia in Brazilian elderly patients
Int Psychogeriatr, 24 (8), 1291-8
DOI 10.1017/S1041610211002250, PubMed 22185723 -
Depression in Alzheimer's disease: specificity of depressive symptoms using three different clinical criteria
Int J Geriatr Psychiatry, 26 (9), 944-51
DOI 10.1002/gps.2631, PubMed 21845597 -
School attainment in childhood is an independent risk factor of dementia in late life: results from a Brazilian sample
Int Psychogeriatr, 24 (1), 55-61
DOI 10.1017/S1041610211001554, PubMed 21813041 -
Quality of life among elderly patients with dementia in institutions
Dement Geriatr Cogn Disord, 31 (6), 435-42
DOI 10.1159/000328969, PubMed 21757909 -
Verbal fluency in Alzheimer's disease, Parkinson's disease, and major depression
Clinics (Sao Paulo), 66 (4), 623-7
DOI 10.1590/s1807-59322011000400017, PubMed 21655757 -
Education does not equally influence all the Mini Mental State Examination subscales and items: inferences from a Brazilian community sample
Braz J Psychiatry, 32 (3), 223-30
DOI 10.1590/s1516-44462010005000009, PubMed 20949237 -
A reliability and validity study of the cornell scale among elderly inpatients, using various clinical criteria
Dement Geriatr Cogn Disord, 29 (5), 438-47
DOI 10.1159/000313533, PubMed 20502018 -
Occurrence of depression and its correlates in early onset dementia patients
Int J Geriatr Psychiatry, 25 (7), 704-11
DOI 10.1002/gps.2411, PubMed 20069586 -
A 12 months follow-up study of depression among nursing-home patients in Norway
J Affect Disord, 120 (1-3), 141-8
DOI 10.1016/j.jad.2009.04.028, PubMed 19467560 -
Factors associated with depression in Norwegian nursing homes
Int J Geriatr Psychiatry, 24 (4), 417-25
DOI 10.1002/gps.2139, PubMed 18836988 -
The pattern of depressive symptoms and factor analysis of the Cornell Scale among patients in Norwegian nursing homes
Int J Geriatr Psychiatry, 23 (10), 1058-65
DOI 10.1002/gps.2033, PubMed 18457344